Eisai Inc. is set to present four-year efficacy and safety data on its Alzheimer's treatment, lecanemab, at the Alzheimer's Association Internation...
Sarepta Therapeutics has announced a halt in shipments of its gene therapy, Elevidys, designed for Duchenne muscular dystrophy. This decision comes...
Minaris Advanced Therapies has announced the appointment of Dr. Orla Cloak as its new Chief Executive Officer. Dr. Cloak brings over 20 years of ex...
Pharmacist Support, a charity dedicated to supporting pharmacists, reported a 23% increase in counselling referrals in 2024 compared to the previou...
Cycle Pharmaceuticals has announced an exclusive partnership with LeMed Specialty Pharmacy for the distribution and services of HARLIKU™ (nitisinon...
Genentech, a subsidiary of Roche, has released mixed results from phase 3 trials of its biologic astegolimab for treating chronic obstructive pulmo...
Jake Retzlaff, a former quarterback for Brigham Young University (BYU), has committed to Tulane University following his withdrawal from BYU due to...
The Washington Post is hosting a live chat event with its food critic, Tom Sietsema, to address questions and concerns from the public regarding di...
Cycle Pharmaceuticals has signed an exclusive U.S. commercialization agreement with Handa Therapeutics for PHYRAGO™ (dasatinib) tablets, an FDA-app...
A recent study has delved into the transcriptomic decoding of surface-based imaging phenotypes, focusing on its application to pharmacotranscriptom...